Citadel Advisors’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Buy
12,600
+6,700
+114% +$1.03M ﹤0.01% 6055
2025
Q4
$809K Buy
+5,900
New +$762K ﹤0.01% 7891
2025
Q2
Sell
-100
Closed -$9.28K 14206
2025
Q1
$9.28K Buy
+100
New +$9.69K ﹤0.01% 13604
2024
Q4
Sell
-1,100
Closed -$138K 15097
2024
Q3
$138K Buy
1,100
+500
+83% +$62.9K ﹤0.01% 10674
2024
Q2
$65K Buy
600
+100
+20% +$9.75K ﹤0.01% 11464
2024
Q1
$47.3K Buy
+500
New +$47.3K ﹤0.01% 12224

Other funds holding NHC

Citadel Advisors's NHC Position: Q1 2026 in Review

Citadel Advisors opened a new position in National Healthcare (NHC) in Q1 2026: 7,942 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #7137 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NHC as recently as Q2 2025.

Citadel Advisors first reported a position in NHC in Q4 2015 and has held it in 30 quarters since. The position peaked at $5.84M in Q1 2023. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Citadel Advisors held 7,942 shares of National Healthcare worth $1.27M as of Q1 2026.
  • National Healthcare was a new Citadel Advisors position in Q1 2026.
  • National Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7137 holding.
  • Citadel Advisors first reported a position in National Healthcare in Q4 2015 and has held it in 30 quarters since.
  • Citadel Advisors's National Healthcare position peaked at $5.84M in Q1 2023.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.